135.68 USD
▲+1.68+1.25%
盘后 146.00 0.00%
2026-11-19
市值
$6.93B
市盈率
—
EPS
-3.05
股息率
—
52 周区间
123.00 – 260.19
成交量
639.65K
Beta
0.83
目标价
264.62
52W 低 123.0052W 高 260.19
价格走势
公司简介
Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States. The company’s commercial product portfolio includes Auvelity (dextromethorphan-bupropion), a N-methyl-D-aspartate receptor antagonist, sigma-1 receptor agonist, aminoketone, and CYP2D6 inhibitor indicated for the treatment of major depressive disorder in adults; Sunosi (solriamfetol), a dopamine and norepinephrine reuptake inhibitor, trace amine-associated receptor 1 ago...